Medical

Sodium-glucose cotransporter-2 ​(SGLT2) inhibitors, also called flozins, began as diabetes drugs. Surprisingly, they turned out to also be very effective at improving heart health. Then they were discovered to slow the progression of chronic kidney ​disease, one of the leading causes of death and disability worldwide. Preliminary evidence indicates... See more